85.17
Schlusskurs vom Vortag:
$84.87
Offen:
$84.87
24-Stunden-Volumen:
201.28K
Relative Volume:
0.54
Marktkapitalisierung:
$4.21B
Einnahmen:
$1.11B
Nettoeinkommen (Verlust:
$205.95M
KGV:
20.72
EPS:
4.11
Netto-Cashflow:
$254.64M
1W Leistung:
+0.82%
1M Leistung:
+1.01%
6M Leistung:
-0.91%
1J Leistung:
+32.36%
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Firmenname
Prestige Consumer Healthcare Inc
Sektor
Telefon
(914) 524-6800
Adresse
660 WHITE PLAINS RD., TARRYTOWN, NY
Vergleichen Sie PBH mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
PBH
Prestige Consumer Healthcare Inc
|
85.16 | 4.24B | 1.11B | 205.95M | 254.64M | 4.11 |
![]()
HLN
Haleon Plc Adr
|
10.96 | 50.54B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
ZTS
Zoetis Inc
|
168.93 | 74.02B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
RDHL
Redhill Biopharma Ltd Adr
|
1.87 | 4.12M | 35.75M | 11.57M | -26.25M | -3.8069 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.05 | 45.57B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.53 | 20.31B | 16.54B | -1.64B | 749.00M | -1.45 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-09 | Herabstufung | Sidoti | Buy → Neutral |
2024-06-21 | Hochstufung | DA Davidson | Neutral → Buy |
2022-11-17 | Eingeleitet | Canaccord Genuity | Buy |
2022-05-10 | Hochstufung | Jefferies | Hold → Buy |
2022-05-09 | Hochstufung | Oppenheimer | Perform → Outperform |
2020-08-07 | Herabstufung | DA Davidson | Buy → Neutral |
2020-06-29 | Hochstufung | Sidoti | Neutral → Buy |
2020-04-14 | Herabstufung | Jefferies | Buy → Hold |
2020-04-07 | Fortgesetzt | Sidoti | Neutral |
2020-03-26 | Hochstufung | Jefferies | Hold → Buy |
2020-03-24 | Eingeleitet | Oppenheimer | Perform |
2020-03-19 | Hochstufung | DA Davidson | Neutral → Buy |
2019-01-15 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2017-12-04 | Hochstufung | William Blair | Mkt Perform → Outperform |
2017-06-02 | Hochstufung | Jefferies | Underperform → Hold |
2017-05-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
2016-12-27 | Bestätigt | B. Riley & Co. | Buy |
2016-11-17 | Eingeleitet | Gabelli & Co | Buy |
2016-08-12 | Hochstufung | Sidoti | Neutral → Buy |
2016-03-08 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
2016-02-05 | Eingeleitet | Piper Jaffray | Overweight |
2015-11-30 | Herabstufung | Jefferies | Hold → Underperform |
2014-04-28 | Bestätigt | B. Riley & Co. | Buy |
2014-04-28 | Bestätigt | Oppenheimer | Outperform |
2013-07-09 | Eingeleitet | B. Riley & Co. | Buy |
Alle ansehen
Prestige Consumer Healthcare Inc Aktie (PBH) Neueste Nachrichten
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick - Yahoo Finance
Zacks Research Issues Optimistic Outlook for PBH Earnings - Defense World
Tidal Investments LLC Sells 1,380 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Equities Analysts Set Expectations for PBH Q1 Earnings - Defense World
Cetera Investment Advisers Invests $413,000 in Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
The Sandlot Star Patrick Renna Teams Up with Dramamine® to Revisit an Iconic SceneThis Time, Puke Free - The Malaysian Reserve
Lice Treatment Market Deep Research Report Identifies Key TrendsPrestige Consumer Healthcare, Reckitt - openPR.com
Prestige Consumer Gains 35.7% in a Year: What's Driving the Stock? - Nasdaq
Prestige Consumer Healthcare Inc. (NYSE:PBH) Holdings Decreased by Nuveen Asset Management LLC - Defense World
Deutsche Bank AG Purchases 14,929 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Prestige Consumer Healthcare Inc. (NYSE:PBH) Position Reduced by Ameriprise Financial Inc. - Defense World
Prestige Consumer Healthcare (NYSE:PBH) Upgraded to “Buy” at StockNews.com - Defense World
Weekly Recap: 14 Health Press Releases You Need to See - Yahoo Finance
Prestige's Diversified Portfolio and Strong Execution Should Drive Steady Growth Across Categories - Morningstar
Prestige Consumer Stock Up 8% Since Q4 Earnings Beat, Margin Increase - MSN
U.S. News Announces the 2025-2026 Best OTC Medicine & Health Products - Morningstar
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q4 2025 Earnings Call Transcript - Insider Monkey
How To Trade (PBH) - news.stocktradersdaily.com
Prestige Consumer Healthcare’s Earnings Call Highlights Growth Amid Challenges - TipRanks
Aussie Stocks Hold Steady With US-China Trade Optimism - Finimize
Prestige Consumer Healthcare (NYSE:PBH) Cut to “Hold” at StockNews.com - Defense World
Prestige Consumer Healthcare Full Year 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Saline Nasal Spray Market to See Ongoing Evolution | Major Giants Pfizer Inc,Bayer AG,Novartis AG - newstrail.com
Jefferies raises Prestige Brands target to $85, maintains Hold rating By Investing.com - Investing.com India
Prestige Consumer Healthcare (NYSE:PBH) Stock Rating Upgraded by Royal Bank of Canada - Defense World
Decoding Prestige Consumer Healthcare Inc (PBH): A Strategic SWO - GuruFocus
Jefferies raises Prestige Brands target to $85, maintains Hold rating - Investing.com
These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Reasonably Well - simplywall.st
Prestige Consumer Healthcare Inc. SEC 10-K Report - TradingView
Prestige Consumer Healthcare Reports Record Fiscal 2025 Results - TipRanks
Prestige Consumer Healthcare: Fiscal Q4 Earnings Snapshot - Greenwich Time
Prestige Consumer Healthcare Q4 2025 Earnings Call Transcript - MarketBeat
Transcript : Prestige Consumer Healthcare Inc., Q4 2025 Earnings Call, May 08, 2025 - marketscreener.com
Prestige: Diversified Portfolio and Strong Execution Drive Steady Growth Across Categories - Morningstar
Premium Brands Holdings (PBH) Target Price Raised by Scotiabank - GuruFocus
Prestige Consumer Healthcare (PBH) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Prestige Consumer Healthcare to Seek M&A - marketscreener.com
UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings | PBH Stock News - GuruFocus
Prestige Consumer Healthcare Inc. Q4 Profit Increases, Beats Estimates - Nasdaq
Prestige Consumer Healthcare (PBH) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance
UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings - Bluefield Daily Telegraph
Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Rev - GuruFocus
Prestige Consumer (PBH) Reports Strong Q4 Revenue and Earnings Growth | PBH Stock News - GuruFocus
Prestige Consumer Healthcare Reports Record Fiscal Year Revenue - TipRanks
Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings - The Manila Times
Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings | PBH Stock News - GuruFocus
Earnings Flash (PBH) Prestige Consumer Healthcare Posts Q4 Revenue $296.5M, vs. FactSet Est of $291.1M - marketscreener.com
Finanzdaten der Prestige Consumer Healthcare Inc-Aktie (PBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):